Cancer Institute A national cancer institute
designated cancer center

Search all open clinical trials at Stanford


Are you thinking of entering a clinical trial? Learn more here.

Español | 中文 | Pусский


View stories from Cancer Clinical Trial participants at Stanford.

Free Class on Wednesday, 9/10: Cancer Clinical Trials and the Future of Care: What You Should Know


Cost of Clinical Trials

If you are considering a clinical trial, the potential cost of being in a trial may factor into your decision to participate. Read more about the different costs for clinical trials here.

S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

This phase I trial studies the side effects and best dose of inotuzumab ozogamicin when given together with combination chemotherapy in treating patients with relapsed or refractory acute leukemia.


Stanford Medicine Resources:

Footer Links: